EP2707005

METHODS TO REDUCE ADVERSE EVENTS CAUSED BY PHARMACEUTICAL PREPARATIONS COMPRISING PLASMA DERIVED PROTEINS

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    14.5.2012
  • EP published:
    23.8.2017
  • EP application number:
    12719993.3
  • Max expiry date:
    13.5.2032
  • Title:
    METHODS TO REDUCE ADVERSE EVENTS CAUSED BY PHARMACEUTICAL PREPARATIONS COMPRISING PLASMA DERIVED PROTEINS

Timeline

Today
14.5.2012EP application
23.8.2017EP Publication

Owner

  • Name:
    CSL Behring GmbH
  • Address:
    Emil-von-Behring-Strasse 76, 35041, Marburg, DE

Inventor

  • Name:
    SCHULTE, Stefan
  • Address:
    Marburg, DE
  • Name:
    KALINA, Uwe
  • Address:
    Marburg, DE
  • Name:
    MOSES, Michael
  • Address:
    Grävenwiesbach, DE
  • Name:
    FEUSSNER, Annette
  • Address:
    Marburg, DE

Priority

  • Number:
    11165869
  • Date:
    12.5.2011
  • Country:
    EP
  • Number:
    201161487205 P
  • Date:
    17.5.2011
  • Country:
    US

Classification

  • Categories:
    A61K 31/727, A61K 35/16, A61K 38/57, A61P 7/02, A61P 1/00, A61P 11/08, A61P 9/06, A61P 9/12

Upload documents